X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14912) 14912
Newspaper Article (577) 577
Book / eBook (120) 120
Book Chapter (107) 107
Dissertation (90) 90
Magazine Article (65) 65
Conference Proceeding (38) 38
Web Resource (26) 26
Government Document (21) 21
Book Review (17) 17
Publication (9) 9
Trade Publication Article (6) 6
Transcript (5) 5
Streaming Video (3) 3
Newsletter (2) 2
Paper (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (11673) 11673
humans (11033) 11033
life sciences & biomedicine (10839) 10839
proto-oncogene proteins b-raf - genetics (6572) 6572
mutation (5170) 5170
animals (4648) 4648
female (4615) 4615
oncology (4556) 4556
male (4308) 4308
middle aged (3171) 3171
aged (2590) 2590
adult (2503) 2503
signal transduction (2453) 2453
cell biology (2441) 2441
mice (2417) 2417
biochemistry & molecular biology (2322) 2322
melanoma (2034) 2034
cell line, tumor (2028) 2028
cancer (1992) 1992
proto-oncogene proteins c-raf - metabolism (1959) 1959
melanoma - genetics (1805) 1805
proto-oncogene proteins b-raf - metabolism (1718) 1718
phosphorylation (1708) 1708
proto-oncogene proteins b-raf - antagonists & inhibitors (1621) 1621
genetic aspects (1528) 1528
braf (1473) 1473
melanoma - drug therapy (1392) 1392
kinases (1369) 1369
tumors (1333) 1333
melanoma - pathology (1293) 1293
research (1280) 1280
pathology (1275) 1275
ras proteins - genetics (1244) 1244
aged, 80 and over (1235) 1235
prognosis (1212) 1212
colorectal neoplasms - genetics (1205) 1205
proteins (1192) 1192
gene mutations (1186) 1186
analysis (1163) 1163
thyroid neoplasms - genetics (1125) 1125
proto-oncogene proteins - genetics (1098) 1098
raf protein (1090) 1090
dna mutational analysis (1077) 1077
colorectal cancer (1072) 1072
ras proteins - metabolism (1065) 1065
metastasis (1054) 1054
apoptosis (1021) 1021
immunohistochemistry (1016) 1016
proto-oncogene proteins c-raf (972) 972
antineoplastic agents - therapeutic use (957) 957
protein-serine-threonine kinases - metabolism (950) 950
raf (949) 949
neoplasms (938) 938
proto-oncogene proteins - metabolism (912) 912
cell line (908) 908
enzyme activation (908) 908
gene expression (901) 901
protein kinase inhibitors - pharmacology (897) 897
rats (892) 892
skin neoplasms - genetics (883) 883
mutation - genetics (874) 874
proto-oncogene proteins c-raf - genetics (864) 864
antineoplastic agents - pharmacology (850) 850
research article (850) 850
signal transduction - drug effects (844) 844
abridged index medicus (836) 836
mitogen-activated protein kinases - metabolism (819) 819
care and treatment (810) 810
colorectal neoplasms - pathology (809) 809
cell proliferation (796) 796
thyroid neoplasms - pathology (790) 790
science & technology - other topics (788) 788
young adult (786) 786
multidisciplinary sciences (766) 766
extracellular signal-regulated map kinases - metabolism (763) 763
gene expression regulation, neoplastic (756) 756
cells, cultured (741) 741
proto-oncogene proteins p21 (739) 739
skin neoplasms - pathology (723) 723
biomarkers, tumor - genetics (722) 722
dermatology (710) 710
raf kinases - metabolism (709) 709
extracellular signal-regulated kinase (708) 708
molecular sequence data (705) 705
treatment outcome (701) 701
adolescent (684) 684
transfection (683) 683
genetics & heredity (682) 682
protein kinase inhibitors - therapeutic use (667) 667
health aspects (660) 660
cell proliferation - drug effects (652) 652
digestive system diseases (652) 652
proto-oncogene proteins p21 - genetics (649) 649
retrospective studies (638) 638
ras (634) 634
neoplasm staging (625) 625
map kinase (617) 617
map kinase signaling system - drug effects (616) 616
melanoma - metabolism (615) 615
map kinase signaling system (614) 614
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (81) 81
Online Resources - Online (26) 26
Collection Dvlpm't (Acquisitions) - Vendor file (16) 16
UTL at Downsview - May be requested (12) 12
Trinity College (John W Graham) - Stacks (7) 7
UofT at Mississauga - Stacks (6) 6
Engineering & Comp. Sci. - Stacks (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Victoria University E.J. Pratt - Stacks (2) 2
Media Commons - Audio Visual (1) 1
UofT at Scarborough - Not Returned (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15433) 15433
Chinese (303) 303
Japanese (109) 109
French (97) 97
German (95) 95
Swedish (33) 33
Russian (30) 30
Spanish (30) 30
Korean (24) 24
Portuguese (21) 21
Turkish (20) 20
Czech (12) 12
Hungarian (11) 11
Italian (8) 8
Polish (8) 8
Norwegian (5) 5
Arabic (4) 4
Dutch (3) 3
Afrikaans (2) 2
Croatian (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Catalan (1) 1
Danish (1) 1
Finnish (1) 1
Fulah (1) 1
Hebrew (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature (London), ISSN 1476-4687, 02/2010, Volume 464, Issue 7287, pp. 427 - 430
Tumours with mutant BRAF are dependent on the RAF–MEK–ERK signalling pathway for their growth. We found that ATP-competitive RAF inhibitors inhibit ERK... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neoplasms - metabolism | ras Proteins - genetics | Phosphorylation | raf Kinases - antagonists & inhibitors | Humans | Protein Multimerization | Transcriptional Activation - drug effects | ras Proteins - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | raf Kinases - metabolism | Mitogen-Activated Protein Kinase Kinases - metabolism | Neoplasms - genetics | Adenosine Triphosphate - metabolism | Indoles - pharmacology | raf Kinases - genetics | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Cell Line | raf Kinases - chemistry | Catalytic Domain | Neoplasms - enzymology | Enzyme Activation - drug effects | Sulfonamides - pharmacology | Neoplasms - drug therapy | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Animals | MAP Kinase Signaling System - drug effects | Models, Biological | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Cell Line, Tumor | Protein Binding | Mice | Protein Kinase Inhibitors - pharmacology | Protein Kinase Inhibitors - metabolism | Care and treatment | Enzyme inhibitors | Gene mutations | Cellular signal transduction | Genetic aspects | Research | Health aspects | Cancer | Proteins | Competition | Drugs | Mutation | Kinases | Tumors | Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 02/2010, Volume 464, Issue 7287, pp. 431 - 435
Activating mutations in KRAS and BRAF are found in more than 30% of all human tumours and 40% of melanoma, respectively, thus targeting this pathway could have... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neoplasms - metabolism | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Diphenylamine - pharmacology | raf Kinases - antagonists & inhibitors | Humans | Protein Multimerization | ras Proteins - metabolism | Protein Transport - drug effects | Extracellular Signal-Regulated MAP Kinases - metabolism | raf Kinases - metabolism | Diphenylamine - analogs & derivatives | Mitogen-Activated Protein Kinase Kinases - metabolism | Adenosine Triphosphate - metabolism | Indoles - pharmacology | Benzamides - pharmacology | Cell Membrane - metabolism | raf Kinases - genetics | Cell Membrane - drug effects | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Pyrazoles - pharmacology | Protein Structure, Tertiary | Proto-Oncogene Proteins - metabolism | Cell Line | Indenes - pharmacology | raf Kinases - chemistry | Proto-Oncogene Proteins c-raf - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Neoplasms - enzymology | Proto-Oncogene Proteins - genetics | Enzyme Activation - drug effects | Sulfonamides - pharmacology | Proto-Oncogene Proteins c-raf - metabolism | Neoplasms - drug therapy | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Animals | MAP Kinase Signaling System - drug effects | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Proto-Oncogene Proteins c-raf - deficiency | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasms - pathology | Ras genes | Growth | Physiological aspects | Cellular signal transduction | Genetic aspects | Research | Mitogen-activated protein kinases | Competition | Clinical trials | Enzymes | Kinases | Index Medicus | Proteins | Cellular | Inhibitors | Pathways | Tumours | Signalling | Dimerization
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 6, pp. 9251 - 9266
Activating mutations in the KRAS and BRAF genes, leading to hyperactivation of the RAS/RAF/MAPK oncogenic signaling cascade, are common in patients with... 
Signaling pathways | Xenograft models | RAS | RAF | Colorectal cancer | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Apoptosis - drug effects | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Humans | Extracellular Signal-Regulated MAP Kinases - metabolism | Rats, Nude | Dose-Response Relationship, Drug | Transfection | RNA Interference | Time Factors | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins A-raf - antagonists & inhibitors | Colorectal Neoplasms - enzymology | Genetic Predisposition to Disease | Proto-Oncogene Proteins c-raf - genetics | HCT116 Cells | Proto-Oncogene Proteins A-raf - genetics | Pyrimidines - pharmacology | Proto-Oncogene Proteins c-raf - metabolism | Proto-Oncogene Proteins A-raf - metabolism | HT29 Cells | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Phenotype | Animals | Tumor Burden - drug effects | Proto-Oncogene Proteins B-raf - genetics | Cell Proliferation - drug effects | Phenylurea Compounds - pharmacology | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-raf - antagonists & inhibitors | Mutation | Colorectal Neoplasms - pathology | G1 Phase Cell Cycle Checkpoints - drug effects | Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 11/2010, Volume 468, Issue 7326, pp. 968 - 972
Oncogenic mutations in the serine/threonine kinase B-RAF (also known as BRAF) are found in 50-70% of malignant melanomas(1). Pre-clinical studies have... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Allosteric Regulation | Humans | Gene Expression Regulation, Neoplastic | Melanoma - enzymology | Gene Expression Profiling | MAP Kinase Signaling System | Mitogen-Activated Protein Kinase Kinases - metabolism | Melanoma - genetics | Indoles - pharmacology | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Gene Library | Proto-Oncogene Proteins c-raf - genetics | MAP Kinase Kinase Kinases - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Proto-Oncogene Proteins - genetics | Clinical Trials as Topic | MAP Kinase Kinase Kinases - metabolism | Enzyme Activation - drug effects | Open Reading Frames - genetics | Sulfonamides - pharmacology | Proto-Oncogene Proteins c-raf - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Drug Resistance, Neoplasm - genetics | Sulfonamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Indoles - therapeutic use | Protein Kinase Inhibitors - pharmacology | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinases - metabolism | Protein research | Research | Properties | Protein kinases | Cancer cells | Cell lines | Biochemistry | Mutation | Kinases | Genes | Cancer | Index Medicus
Journal Article